InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,071.63
(
0.02%
)
US TECH 100
16,922.40
(
-0.81%
)
Dow Jones
38,460.92
(
-0.11%
)
Brent Oil
87.03
(
-0.22%
)
Bitcoin
63,893.17
(
-0.60%
)
Post# of 251590
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 827
Posts 119469
Boards Moderated 15
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Bickema post# 214086

Monday, 12/11/2017 6:45:51 PM

Monday, December 11, 2017 6:45:51 PM

Post# of 251590
(MNTA)—TEVA drops Copaxone lawsuit against MYL on ‘775 and ‘993 (non-Orange-Book) manufacturing patents after US District Court sides with MYL in Markman hearing:

https://www.prnewswire.com/news-releases/teva-dismisses-litigation-after-mylan-wins-us-court-ruling-related-to-tevas-cold-filtration-patents-for-copaxone-40-mgml-300569596.html

According to the CEO, MNTA designed around TEVA’s Copaxone-manufacturing patents and hence was never at risk from the lawsuit in question.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up